英文名稱 |
中文名稱 |
CAS號 |
操作 |
Vantictumab |
萬替妥單抗 |
1345009-45-1 |
詳細
|
Vc-seco-DUBA |
VC-SECO-DUBA |
1345681-58-4 |
詳細
|
MPT0B392 |
MPT0B392 |
1346169-92-3 |
詳細
|
Enfortumab vedotin-ejfv |
維汀-恩弗妥單抗 |
1346452-25-2 |
詳細
|
DHODH-IN-23 |
化合物DHODH-IN-23 |
1346705-53-0 |
詳細
|
NSC639828 |
NSC 639828 |
134742-26-0 |
詳細
|
Guselkumab |
古塞庫單抗 |
1350289-85-8 |
詳細
|
Margetuximab |
瑪格妥昔單抗 |
1350624-75-7 |
詳細
|
ONC1-13B |
Benzamide, 4-[(5R)-3-[4-cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]non-1-yl]-2-fluoro-N-methyl- |
1351185-54-0 |
詳細
|
Obiltoxaximab |
Obiltoxaximab |
1351337-07-9 |
詳細
|
Pritoxaximab |
Pritoxaximab |
1351470-16-0 |
詳細
|
Setoxaximab |
Setoxaximab |
1351470-17-1 |
詳細
|
GSK299423 |
化合物 T32008 |
1352149-24-6 |
詳細
|
EW-7195 |
化合物 EW-7195 |
1352609-28-9 |
詳細
|
TG-2-IN-1 |
化合物 TG-2-IN-1 |
135273-74-4 |
詳細
|
MIV-247 |
MIV-247 |
1352817-76-5 |
詳細
|
(2RS)-FPMPA |
化合物(2RS)-FPMPA |
135295-27-1 |
詳細
|
Trazpiroben |
TRAZPIROBEN |
1352993-39-5 |
詳細
|
Enoblituzumab |
MGA271 |
1353485-38-7 |
詳細
|
γ-Secretase modulator 13 |
化合物 Γ-SECRETASE MODULATOR 13 |
1353570-40-7 |
詳細
|
UNC0006 |
化合物 T29061 |
1354030-14-0 |
詳細
|
UNC9975 |
化合物 T29064 |
1354030-19-5 |
詳細
|
UNC9995 |
5-(3-(4-(2,3-二氯苯基)哌嗪-1-基)丙氧基)苯并[D]噻唑 |
1354030-52-6 |
詳細
|
FL118 |
FL118 |
135415-73-5 |
詳細
|
Lodelcizumab |
Lodelcizumab |
1355338-54-3 |
詳細
|
OTS447 |
化合物 OTS447 |
1356943-67-3 |
詳細
|
Fletikumab |
夫來庫單抗 |
1357158-22-5 |
詳細
|
(4R)-RO5263397 |
化合物 (4R)-RO5263397 |
1357266-80-8 |
詳細
|
UBE2T/FANCL-IN-1 |
UBE2T/FANCL-IN-1 |
1359415-02-3 |
詳細
|
Fosopamine(HCl) |
鹽酸磷巴胺 |
135962-35-5 |
詳細
|
RTC13 |
RTC13 |
1359825-94-7 |
詳細
|
Tarextumab |
Tarextumab |
1359940-55-8 |
詳細
|
PI3K-IN-31 |
化合物 PI3K-IN-31 |
1359956-12-9 |
詳細
|
Nexopamil |
奈索帕米 |
136033-49-3 |
詳細
|
M3541 |
化合物M3541 |
1360628-91-6 |
詳細
|
Antioxidant agent-1 |
化合物 ANTIOXIDANT AGENT-1 |
136068-43-4 |
詳細
|
DSPE-Mal |
DSPE-馬來酰亞胺 |
1360858-99-6 |
詳細
|
AMG-1694 |
AMG-1694 |
1361217-07-3 |
詳細
|
ACT-462206 |
(2S)-N-(3,5-DIMETHYLPHENYL)-1-(4-METHOXYPHENYL)SULFONYLPYRROLIDINE-2-CARBOXAMIDE |
1361321-96-1 |
詳細
|
Fluorizoline |
Thiazole, 2,5-bis(4-chlorophenyl)-4,4,5-trifluoro-4,5-dihydro- |
1362243-70-6 |
詳細
|
Idarucizumab |
Idarucizumab |
1362509-93-0 |
詳細
|
Codrituzumab |
考曲妥珠單抗 |
1365267-33-9 |
詳細
|
Emibetuzumab |
Emibetuzumab |
1365287-97-3 |
詳細
|
KP-457 |
KP-457 |
1365803-52-6 |
詳細
|
NS-102 |
NS 102 |
136623-01-3 |
詳細
|
Mopidamol |
莫哌達醇 |
13665-88-8 |
詳細
|
Atevirdine |
阿替韋啶 |
136816-75-6 |
詳細
|
Sophoraflavanone H |
(2S)-5,7-Dihydroxy-2,3-dihydro-2α-[[(2R)-2β-(4-hydroxyphenyl)-3α-(3,5-dihydroxyphenyl)-6-hydroxy-2,3-dihydrobenzofuran]-5-yl]-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
136997-68-7 |
詳細
|
CUR5g |
化合物 CUR5G |
1370032-20-4 |
詳細
|
Anatumomab mafenatox |
安那莫單抗 |
1370261-50-9 |
詳細
|
P505-15 Acetate |
化合物 T24584 |
1370261-98-5 |
詳細
|
Nisin Z |
乳酸鏈球菌素Z |
137061-46-2 |
詳細
|
Cassiaside |
4H-Naphtho[2,3-b]pyran-4-one, 6-(β-D-glucopyranosyloxy)-5,8-dihydroxy-2-methyl- |
13709-03-0 |
詳細
|
Turosteride |
妥羅雄脲 |
137099-09-3 |
詳細
|
Aptiganel |
化合物 T26645 |
137159-92-3 |
詳細
|
Iliparcil |
伊利帕西 |
137214-72-3 |
詳細
|
THX-B |
7H-Purine-7-acetamide, 1,2,3,6-tetrahydro-1,3-dimethyl-N-(1-methylethyl)-N-[[(1-methylethyl)amino]carbonyl]-2,6-dioxo- |
1372206-64-8 |
詳細
|
Osemozotan HCl |
5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride |
137275-80-0 |
詳細
|
Tosatoxumab |
Tosatoxumab |
1374419-41-6 |
詳細
|
SCFSkp2-IN-2 |
化合物SCFSKP2-IN-2 |
1375060-02-8 |
詳細
|
Kukoamine B mesylate |
地骨皮乙素 甲磺酸鹽 |
1375179-86-4 |
詳細
|
Anetumab ravtansine |
Anetumab Ravtansine |
1375258-01-7 |
詳細
|
Ulocuplumab |
Ulocuplumab |
1375830-34-4 |
詳細
|
LY3020371 hydrochloride |
LY3020371 HYDROCHLORIDE |
1377615-44-5 |
詳細
|
Zifaxaban |
Zifaxaban |
1378266-98-8 |
詳細
|
CPI-0610 carboxylic acid |
CPI-0610 CARBOXYLIC ACID |
1380089-81-5 |
詳細
|
GAL-021 sulfate |
化合物 GAL-021 SULFATE |
1380342-00-6 |
詳細
|
Kv3 modulator 1 |
KV3 MODULATOR 1 |
1380696-64-9 |
詳細
|
D-Glucose-1,2-13C2 |
D-葡萄糖-1,2-13C2 |
138079-87-5 |
詳細
|
TBK1/IKKε-IN-4 |
TBK1/IKKΕ-IN-4 |
1381930-17-1 |
詳細
|
DpC |
Di-2-pyridylketone-4-cyclohexyl-4-methyl-3-thiosemicarbazone |
1382469-39-7 |
詳細
|
MpsBAY2a |
N-Cyclopropyl-4-[8-[(2-methylpropyl)amino]-6-(5-quinolinyl)imidazo[1,2-a]pyrazin-3-yl]benzamide |
1382477-96-4 |
詳細
|
PI3K-IN-38 |
化合物 PI3K-IN-38 |
1382979-64-7 |
詳細
|
IHVR-11029 |
3,4,5-Piperidinetriol, 1-[6-(2,5-difluorophenoxy)hexyl]-2-(hydroxymethyl)-, (2R,3R,4R,5S)- |
1383152-30-4 |
詳細
|
DSPE-NHS |
DSPE-NHS |
1383932-86-2 |
詳細
|
Diphlorethohydroxycarmalol |
|
138529-04-1 |
詳細
|
Nolomirole HCl |
化合物 T33711L |
138531-51-8 |
詳細
|
ADR-851 free base |
化合物 T23642 |
138559-56-5 |
詳細
|
Nebacumab |
奈巴庫單抗 |
138661-01-5 |
詳細
|
Furnidipine |
呋尼地平 |
138661-03-7 |
詳細
|
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- |
化合物T77608 |
138801-72-6 |
詳細
|
NorA-IN-1 |
E)-1-(4-Hydroxy-phenyl)-3-(2,4,6-trimethoxy-phenyl)-propenone |
1389310-69-3 |
詳細
|
ME1111 |
ME1111 |
1391758-52-3 |
詳細
|
Varlilumab |
伐立魯單抗 |
1393344-72-3 |
詳細
|
Temelimab |
替西木單抗 |
1393641-34-3 |
詳細
|
Diridavumab |
Diridavumab |
1393659-46-5 |
詳細
|
8alpha-Hydroxyhirsutinolide |
8ALPHA-羥基硬毛鉤藤內(nèi)酯 |
1394156-45-6 |
詳細
|
(+)-Picumeterol |
吡庫特羅異構(gòu)體 |
139423-79-3 |
詳細
|
Golgicide A-2 |
GOLGICIDE A-2 |
1394285-50-7 |
詳細
|
LPA1 receptor antagonist 1 |
Cyclopropanecarboxylic acid, 1-[4'-[4-Methyl-5-[[[(1R)-1-phenylethoxy]carbonyl]aMino]-1H-1,2,3-triazol-1-yl][1,1'-biphenyl]-4-yl]- |
1396006-71-5 |
詳細
|
Anti-amyloid agent-1 |
化合物 ANTI-AMYLOID AGENT-1 |
1396778-73-6 |
詳細
|
Spiroglumide |
螺谷胺 |
137795-35-8 |
詳細
|
Sigma-LIGAND-1 hydrochloride |
化合物 SIGMA-LIGAND-1 HYDROCHLORIDE |
139652-86-1 |
詳細
|
Golgicide A-1 |
GOLGICIDE A-1 |
1394285-49-4 |
詳細
|
ERD03 |
化合物 ERD03 |
1377897-01-2 |
詳細
|
CP 96021 |
化合物CP 96021 |
139401-43-7 |
詳細
|
2,3-Bis(3-indolylmethyl)indole |
2,3-BIS(3-INDOLYLMETHYL)INDOLE |
138250-72-3 |
詳細
|
Tuvirumab |
Tuvirumab |
138660-97-6 |
詳細
|
Sevirumab |
司韋單抗 |
138660-96-5 |
詳細
|
CGP-20712 |
2-羥基-5-[2-[[2-羥基-3-[4-[1-甲基-4-(三氟甲基)-1H-咪唑-2-基]苯氧基]丙基]氨基]乙氧基]苯甲酰胺 |
137888-49-4 |
詳細
|